Status:
TERMINATED
A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
Lead Sponsor:
Loma Linda University
Conditions:
Renal Transplant Rejection
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This study aims to compare outcomes in renal transplant recipients in the hispanic population based on their immunosuppressant regimens.
Detailed Description
This study aims to include Hispanics who have undergone a renal transplant to determine the specific outcome after renal transplantation, assuming that ethnic groups require different immunosuppressan...
Eligibility Criteria
Inclusion
- Cadaveric or Living Donors
- 18 years old or greater
- Primary renal transplants
- Hispanic ethnicity
Exclusion
- Prior renal transplant
- Multi-organ transplant
- Recipient with history of Diabetes Mellitus
- PRA \> 20%
- Cold Ischemia Time \> 24 hours
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00983645
Start Date
October 1 2004
End Date
March 1 2013
Last Update
June 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Medical Center
Loma Linda, California, United States, 92354